NO923619L - Fremstilling av krystallinsk penem - Google Patents

Fremstilling av krystallinsk penem

Info

Publication number
NO923619L
NO923619L NO92923619A NO923619A NO923619L NO 923619 L NO923619 L NO 923619L NO 92923619 A NO92923619 A NO 92923619A NO 923619 A NO923619 A NO 923619A NO 923619 L NO923619 L NO 923619L
Authority
NO
Norway
Prior art keywords
preparation
crystallization
smaller
carried out
temperatures
Prior art date
Application number
NO92923619A
Other languages
English (en)
Norwegian (no)
Other versions
NO923619D0 (no
Inventor
Masayoshi Kaneko
Shigeo Yabuno
Original Assignee
Lederle Japan Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd, Takeda Chemical Industries Ltd filed Critical Lederle Japan Ltd
Publication of NO923619D0 publication Critical patent/NO923619D0/no
Publication of NO923619L publication Critical patent/NO923619L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO92923619A 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem NO923619L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24164891 1991-09-20

Publications (2)

Publication Number Publication Date
NO923619D0 NO923619D0 (no) 1992-09-17
NO923619L true NO923619L (no) 1993-03-22

Family

ID=17077445

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92923619A NO923619L (no) 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem
NO971332A NO971332D0 (no) 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO971332A NO971332D0 (no) 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem

Country Status (9)

Country Link
US (2) US5286856A (cs)
EP (1) EP0533149A1 (cs)
JP (1) JP2767171B2 (cs)
KR (1) KR930006022A (cs)
FI (1) FI924210L (cs)
IL (1) IL103218A0 (cs)
NO (2) NO923619L (cs)
TW (1) TW264475B (cs)
ZA (1) ZA927164B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW264475B (cs) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
WO1999045010A1 (en) * 1998-03-02 1999-09-10 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
DE10300620B4 (de) * 2002-05-18 2017-04-13 Carl Zeiss Meditec Ag Trägervorrichtung für ein medizinisch-optisches Gerät
KR101013535B1 (ko) * 2004-10-21 2011-02-14 주식회사 만도 자동차의 파워 스티어링 장치용 실린더 튜브와 피드튜브의 조립 구조물
HUE028503T2 (en) 2006-09-25 2016-12-28 Ptc Therapeutics Inc Crystalline Forms of 3- [5- (2-Fluorophenyl) - [1,2,4] oxadiazol-3-yl] benzoic acid
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
DE102008043318A1 (de) 2008-10-30 2010-05-12 Mvg Metallverarbeitungsgesellschaft Mbh Anhängekupplung
WO2013132422A1 (en) * 2012-03-05 2013-09-12 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of carbapenem antibiotic
WO2013180197A1 (ja) 2012-05-30 2013-12-05 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 新規β－ラクタマーゼ阻害剤とその製造法
WO2014097221A1 (en) 2012-12-21 2014-06-26 Ranbaxy Laboratories Limited Process for the purification of biapenem
MX372585B (es) 2013-09-24 2020-04-17 Meiji Seika Pharma Co Ltd Proceso para producir derivado de diazabiciclooctano y su intermediario
CA2926071C (en) 2013-10-08 2021-11-09 Meiji Seika Pharma Co., Ltd. Crystalline forms of diazabicyclooctane derivative and production process thereof
SG11201704576SA (en) 2014-12-05 2017-07-28 Meiji Seika Pharma Co Ltd Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
CN114349772B (zh) * 2020-10-13 2022-11-25 珠海联邦制药股份有限公司 一种比阿培南粗品的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
JPS6024080B2 (ja) * 1977-06-01 1985-06-11 武田薬品工業株式会社 結晶の製造法
GB1589317A (en) * 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS56120615A (en) * 1980-02-27 1981-09-22 Nippon Chemiphar Co Ltd Preparation of lyophilized powder of cephalothin
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
JPS6425779A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
US4866171A (en) * 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
GB9021061D0 (en) * 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
TW264475B (cs) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
RU2127275C1 (ru) * 1993-01-29 1999-03-10 Агурон Фармасьютикалз, Инк. 2-[4-[2-(2-амино-4-оксо-4,6,7,8-тетрагидро-3h-пиримидо[5,4-b] [1,4]тиазин-6- ил)этил] бензоил(или тиенилкарбонил)амино]пентандиовая кислота или ее низший алкиловый эфир, способ ингибирования роста и пролиферации клеток и способ ингибирования фермента

Also Published As

Publication number Publication date
KR930006022A (ko) 1993-04-20
AU2459792A (en) 1993-03-25
JP2767171B2 (ja) 1998-06-18
EP0533149A1 (en) 1993-03-24
NO971332L (no) 1993-03-22
US5424069A (en) 1995-06-13
AU645442B2 (en) 1994-01-13
JPH05271241A (ja) 1993-10-19
TW264475B (cs) 1995-12-01
IL103218A0 (en) 1993-02-21
ZA927164B (en) 1994-03-18
NO923619D0 (no) 1992-09-17
FI924210A7 (fi) 1993-03-21
FI924210A0 (fi) 1992-09-18
FI924210L (fi) 1993-03-21
NO971332D0 (no) 1997-03-21
US5286856A (en) 1994-02-15

Similar Documents

Publication Publication Date Title
NO923619L (no) Fremstilling av krystallinsk penem
NO982500D0 (no) FremgangsmÕte for fremstilling av S(-)natrium 2-(4-isobutylfenyl) propionat med h°y enantiomer renhet, samt forbindelsen dihydratet derav som sÕdan
FI943687A0 (fi) Uudet 11-bentsaldoksiimiestradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
IE791565L (en) Crop cutting apparatus
NO304988B1 (no) 11-benzaldoksim-17<beta>-metoksy-17<alfa>-metoksymetyl-°stradienderivater samt farmas°ytisk preparat inneholdende slike
AU2353395A (en) Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
EP1332145B1 (en) Process for formulation of antibiotic compounds
AU2001261079A1 (en) Process for formulation of antibiotic compounds
NO170330B (no) Fremgangsmaate for fremstilling av vesentlig optisk rent monohydrat av s-(-)-propyl-2',6'-pipekoloksylididhydroklorid
NO960268L (no) Nye dialkoksypyridinylbenzimidazolderivater
IT8224624A1 (it) Sale metilglucamminico del flurbiprofen dotato di attivita' terapeutica e procedimento per la sua preparazione
JPS6051172A (ja) ピロリジノン誘導体
JPS6479180A (en) Carbapenem compound in crystal form, production thereof and composition containing said compound for injection
FI103576B1 (fi) Menetelmä lääkeaineena käyttökelpoisen kiteisen karbapeneemijohdannaisen valmistamiseksi
NO176102C (no) Fremgangsmåte ved fremstilling av carbapenemderivater og deres utgangsmaterialer
US6486150B2 (en) Process for formulation of antibiotic compounds
GR1002251B (en) Process for preparing clystalline (5r,6s)-2-carbamouloxymethyl-6-£(1r)-hydroxyethyl|-2-penem-carboxylic acid and its pharmaceutical formulation
JPS61172878A (ja) カルバペネム誘導体の安定な凍結乾燥製剤の製法
DK411488D0 (da) (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaader til deres fremstilling samt deres anvendelse
GB1187784A (en) Strengthening Glassware
ES8600767A1 (es) Un procedimiento para la preparacion de derivados de 7-oxo-1-azabiciclo (3.2.0) hepteno
JPS56147733A (en) Optically active alcoholic compound and its preparation
CN1086315A (zh) 食品卫生检测标准溶液安瓿制剂生产方法
NO986185L (no) 7-brom- og 7,7-dibrom-cefam- og -cefem-derivater
FI921681A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-(heterosyklyylitio)karbapeneemijohdannaisten valmistamiseksi